• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过热重分析和红外分析联用对药物溶剂化物进行表征

Characterization of pharmaceutical solvates by combined thermogravimetric and infrared analysis.

作者信息

Rodriguez C, Bugay D E

机构信息

Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903, USA.

出版信息

J Pharm Sci. 1997 Feb;86(2):263-6. doi: 10.1021/js960286z.

DOI:10.1021/js960286z
PMID:9040107
Abstract

The combined physical analytical technique of thermogravimetric and infrared analysis (TG/IR) is described for the investigation of pharmaceutical solids. TG/IR provides an unequivocal identification of the volatile content of a pharmaceutical solid. In the case of pharmaceutical solvates, TG/IR provides identification of the evolved gas from the crystalline solid. Variable temperature X-ray diffraction and differential scanning calorimetry techniques provide the required information to ascertain whether the evolved gas was due to a solvent incorporated into the crystal lattice or physically adsorbed onto the solid. This work illustrates three examples of TG/IR as utilized in a multidisciplinary approach to the physical characterization of pharmaceutical solids.

摘要

描述了用于研究药物固体的热重分析和红外分析相结合的物理分析技术(TG/IR)。TG/IR能明确鉴定药物固体的挥发性成分。对于药物溶剂化物,TG/IR能鉴定出从结晶固体中逸出的气体。可变温度X射线衍射和差示扫描量热法技术提供了所需信息,以确定逸出的气体是由于晶格中掺入的溶剂还是物理吸附在固体上。这项工作展示了TG/IR在多学科方法中用于药物固体物理表征的三个例子。

相似文献

1
Characterization of pharmaceutical solvates by combined thermogravimetric and infrared analysis.通过热重分析和红外分析联用对药物溶剂化物进行表征
J Pharm Sci. 1997 Feb;86(2):263-6. doi: 10.1021/js960286z.
2
Polymorphism of sulindac: isolation and characterization of a new polymorph and three new solvates.舒林酸的多晶型:一种新多晶型物和三种新溶剂化物的分离与表征
J Pharm Sci. 1997 Feb;86(2):248-51. doi: 10.1021/js9601748.
3
Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate.富马酸替诺福韦二异丙酯的同晶型溶剂化物和多晶型的有机蒸汽吸附法。
Eur J Pharm Sci. 2013 Nov 20;50(3-4):253-62. doi: 10.1016/j.ejps.2013.07.004. Epub 2013 Jul 18.
4
IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.红外光谱法结合多变量数据分析,作为一种过程分析工具,用于结晶过程的在线监测和结晶产物的固态分析。
J Pharm Biomed Anal. 2005 Jun 15;38(2):275-84. doi: 10.1016/j.jpba.2005.01.009.
5
Determination of the polymorphic forms of bicifadine hydrochloride by differential scanning calorimetry-thermogravimetric analysis, X-ray powder diffraction, attenuated total reflectance-infrared spectroscopy, and attenuated total reflectance-near-infrared spectroscopy.采用差示扫描量热法-热重分析法、X射线粉末衍射法、衰减全反射红外光谱法和衰减全反射近红外光谱法测定盐酸比西发定的多晶型。
Appl Spectrosc. 2005 Nov;59(11):1365-71. doi: 10.1366/000370205774783322.
6
Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.抗生素利福霉素衍生物利法米昔的多态性-结构关系
Mol Pharmacol. 1995 Mar;47(3):611-23.
7
Solvates of the antifungal drug griseofulvin: structural, thermochemical and conformational analysis.抗真菌药物灰黄霉素的溶剂化物:结构、热化学及构象分析
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2014 Feb;70(Pt 1):54-62. doi: 10.1107/S2052520613026711. Epub 2013 Dec 10.
8
[Advances in the quantitative analytical methods of drug polymorphism].[药物多晶型定量分析方法的研究进展]
Yao Xue Xue Bao. 2011 Aug;46(8):896-903.
9
[Preparation and characterization of solid dispersions of ginkgolides].[银杏内酯固体分散体的制备与表征]
Zhongguo Zhong Yao Za Zhi. 2009 Jun;34(11):1368-72.
10
Determination of co-crystal phase purity by mid infrared spectroscopy and multiple curve resolution.用中红外光谱和多曲线分辨率测定共晶相纯度。
Int J Pharm. 2021 Feb 15;595:120246. doi: 10.1016/j.ijpharm.2021.120246. Epub 2021 Jan 20.

引用本文的文献

1
Pharmaceutical Salts: Comprehensive Insights From Fundamental Chemistry to FDA Approvals (2019-2023).药用盐:从基础化学到美国食品药品监督管理局批准的全面洞察(2019 - 2023年)
AAPS PharmSciTech. 2025 Jan 16;26(1):36. doi: 10.1208/s12249-024-03020-4.